Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

527.78
-19.8900-3.63%
Post-market: 529.401.62+0.31%19:55 EDT
Volume:1.50M
Turnover:803.69M
Market Cap:57.00B
PE:13.39
High:552.84
Open:549.00
Low:527.13
Close:547.67
Loading ...

Refile-Regeneron Pharmaceuticals Inc : Morgan Stanley Cuts Target Price to $1081.00 From $1150.00 (Clarifies Company Name)

THOMSON REUTERS
·
09 Apr

Morgan Stanley Sticks to Its Buy Rating for Regeneron (REGN)

TIPRANKS
·
09 Apr

Pharma Stocks Sink After Trump Says "Major" Tariffs Are Coming

Tiger Newspress
·
09 Apr

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
09 Apr

Jefferies Adjusts Regeneron Pharmaceuticals' Price Target to $936 rom $1,120, Keeps Buy Rating

MT Newswires Live
·
07 Apr

Regeneron Pharmaceuticals Inc : Jefferies Cuts Target Price to $936 From $1120

THOMSON REUTERS
·
07 Apr

Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)

StockStory
·
07 Apr

Regeneron Pharmaceuticals (NasdaqGS:REGN) Drops 10% Over Last Week Despite Dupixent Approval in Japan

Simply Wall St.
·
06 Apr

Pharma Stocks Survive Market Rout on Tariff Exemption, but Uncertainty Continues

Reuters
·
03 Apr

Regeneron Pharmaceuticals Inc : RBC Raises Target Price to $1051 From $1045

THOMSON REUTERS
·
03 Apr

Bernstein Adjusts PT on Regeneron Pharmaceuticals to $979 From $1,010, Maintains Outperform Rating

MT Newswires Live
·
03 Apr

BUZZ-US drugmakers fall after Trump announces reciprocal tariffs

Reuters
·
03 Apr

Regeneron Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
02 Apr

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks
·
01 Apr

Regeneron Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $780 From $834

THOMSON REUTERS
·
01 Apr

Regeneron Pharma Is Maintained at Overweight by JP Morgan

Dow Jones
·
31 Mar

Intellia Focuses on Pipeline Development Amid Stiff Competition

Zacks
·
31 Mar

Pharma Stocks Sink After Ouster of Top FDA Vaccine Regulator

Reuters
·
31 Mar

3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy Space

Zacks
·
31 Mar

JPMorgan Adjusts PT on Regeneron Pharmaceuticals to $1,000 From $1,100, Maintains Overweight Rating

MT Newswires Live
·
31 Mar